Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone lesions in multiple myeloma]

M Umeda1, M Takata

  • 1First Department of Internal Medicine, Toho University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative evaluation of pleural adhesions with dynamic chest radiography: a retrospective study of 146 patients with lung cancer.

Clinical radiology·2022
Same author

Basal cell carcinoma on the ventral site of the finger with an intronic deletion of SUFU gene.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Asteroseismic detection of latitudinal differential rotation in 13 Sun-like stars.

Science (New York, N.Y.)·2018
Same author

Characteristics of adverse drug reactions in a vemurafenib early post-marketing phase vigilance study in Japan.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2017
Same author

Heat-Treatment-Induced Switching of Magnetic States in the Doped Polar Semiconductor Ge1-xMnxTe.

Scientific reports·2016
Same author

Contemporary evolution of host plant range expansion in an introduced herbivorous beetle Ophraella communa.

Journal of evolutionary biology·2016
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Multiple myeloma (MM) causes bone lesions due to osteoclast-activating factors. New diphosphate treatments show promise for managing these debilitating bone lesions in MM patients.

Area of Science:

  • Oncology
  • Pathophysiology
  • Pharmacology

Context:

  • Multiple myeloma (MM) is characterized by the proliferation of plasma cells, often leading to significant bone lesions.
  • Understanding the factors that activate osteoclasts is crucial for managing MM bone disease.
  • Existing treatments for MM bone lesions have limitations, necessitating novel therapeutic approaches.

Purpose:

  • To review the etiology and pathophysiology of bone lesions in multiple myeloma.
  • To discuss the role of osteoclast-activating factors (OAFs) in MM bone disease.
  • To highlight new therapeutic strategies, specifically diphosphates, for treating bone lesions in MM.

Summary:

  • Bone lesions in multiple myeloma are driven by osteoclast-activating factors (OAFs) such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1.

Related Experiment Videos

  • Patients with multiple bone lesions often exhibit low bone mineral density and reduced 1,25-hydroxyvitamin D levels.
  • Dual-energy X-ray absorptiometry is a valuable tool for assessing bone lesions in MM.
  • New diphosphates that inhibit osteoclast activity are emerging as a promising treatment for MM bone lesions.

    • Impact:

    • This review provides insights into the mechanisms underlying MM bone disease.
    • It highlights the potential of novel diphosphate therapies for improving patient outcomes.
    • Enhanced understanding can guide future research and clinical management of multiple myeloma bone complications.